Operational Bias as a Causal Pathway

Why Access Can Become a Causal Concern

Interim treatment comparisons are produced for a reason: they may inform a planned decision during a trial. But information can also affect what people do or how outcomes are recorded. If access changes trial conduct differently across treatment groups, the final comparison may reflect both treatment assignment and the consequences of that changed conduct. The concern is not simply that someone saw a result. It is that access could initiate a pathway that changes the data relevant to the trial’s intended question.

A causal diagram makes this possibility explicit. It helps separate the event of having access from the downstream behavior or conduct that might follow, and from the outcome ultimately analyzed. The diagram describes a proposed mechanism; drawing an arrow does not establish that the mechanism occurred or quantify its effect.

A Simple Causal Diagram

Use the following nodes: \(A\) is randomized treatment assignment; \(K\) indicates that a person or team has access to an interim comparison; \(B\) is behavior that may change in response; \(C\) is a resulting feature of trial conduct, such as care delivered; \(Y^*\) is the outcome that would be defined under the intended measurement process; \(M\) represents measurement or recording differences; and \(Y_{\text{obs}}\) is the recorded outcome.

The first line reminds us that assignment can affect the outcome and that the recorded value represents the outcome through a measurement process. The second line shows two possible pathways from access: changed conduct may affect the outcome itself, or changed behavior may affect how it is measured or recorded. In a particular trial, there may be other paths, including no consequential path at all. For example, access might not change behavior, or a changed behavior might have no effect on the endpoint.

The diagram is a causal hypothesis, not a data summary. Its arrows express claims about possible cause and effect, not correlations. A treatment group difference in recorded outcomes does not, by itself, establish that access caused a difference. Conversely, random assignment of \(A\) does not guarantee that conduct and measurement remain comparable after randomization. It primarily supports a fair comparison of assignment under the trial conditions; it cannot erase a later, access-related change in care or assessment.

What the Observed Contrast Contains

A short decomposition clarifies one measurement pathway. Suppose the outcome is quantitative and the recorded outcome can be represented as the intended outcome plus a measurement or recording shift:

Here, \(M\) is an additive difference between the recorded value and the intended value; it may vary across participants and treatment groups. If \(A=1\) denotes one assigned treatment and \(A=0\) the comparator, the difference in average recorded outcomes is:

This follows by substituting \(Y_{\text{obs}}=Y^*+M\) into each group mean and using the linearity of expectation. The first bracket is the contrast in intended outcomes; the second is differential measurement or recording. If the expected shift is the same in both groups, the second bracket is zero and does not change the contrast in this additive model. If the shift differs by group, the recorded contrast includes that difference.

This decomposition is a justification, not a general correction formula. It assumes a meaningful additive scale and that \(M\) captures the relevant measurement difference. It does not identify the intended-outcome contrast from observed data without information about \(M\). For binary outcomes or other scales, the relationship must be represented on the appropriate scale rather than automatically using this additive equation.

Worked Pathways Through Trial Conduct

Not every relevant pathway is a measurement shift. Access could change what happens during follow-up, which may change participants’ outcomes. Whether that change is bias depends on the trial question. For instance, if the question concerns assignment under the care conditions actually delivered, an access-related change in care may be part of the treatment-policy effect being estimated. If the intended question concerns treatment under standardized co-interventions, the same change may make the observed comparison depart from that target. State the estimand—the treatment effect the trial intends to estimate—before labeling a pathway as bias.

A pathway may also begin with participants’ expectations and end with a subjective outcome report. The outcome is not automatically invalid because it is self-reported. Rather, the concern is whether knowledge or expectations alter reporting in a way that differs between groups and matters for the intended interpretation.

Assumptions, Diagnostics, and Limits

A causal interpretation requires more than a plausible diagram. First, define the target contrast and endpoint precisely. Second, specify who had access, when, and what behavior or conduct could follow. Third, establish that the proposed cause preceded the behavior, and that the behavior preceded the outcome or recording change. Finally, assess alternative explanations, such as changes in participant composition, ordinary site variation, or unrelated changes in measurement practice. Without these steps, the diagram is best treated as a structured risk assessment rather than an estimated causal effect.

Useful diagnostics look for evidence along the pathway, not just a final group difference. Examples include comparing access records with timing of changed procedures, reviewing outcome forms for patterns in missingness or classification, and checking whether relevant care differed as the trial proceeded. A pattern consistent with the proposed pathway strengthens concern but does not, alone, prove causation: other time-varying changes could produce a similar pattern. A lack of detected differences can also be inconclusive if records are incomplete or the diagnostic measure is insensitive.

Several safeguards address different parts of the diagram. Randomization addresses baseline comparability of assigned groups, but not necessarily differential post-randomization conduct. Masked or otherwise independent outcome assessment can reduce some measurement pathways, but does not prevent every change in care or participant reporting. Access audits can establish who could see information and when; they do not, by themselves, show that behavior changed. These approaches complement rather than replace one another.

A causal diagram and a statistical adjustment are not interchangeable. If behavior or care lies on the pathway from access to outcome, adjusting for it may remove part of the pathway one is trying to describe. It can also introduce bias if the adjustment variable is related to other causes of the outcome. Adjustment may be appropriate for a clearly defined estimand and a justified analysis, but a list of measured covariates is not a substitute for causal reasoning.

Common Mistakes

• “Someone had access, so the treatment comparison is biased.” Access creates a possible pathway. If it does not change behavior or conduct relevant to the outcome, it may have no effect on the comparison.
• “Randomization prevents operational bias.” Randomization supports baseline comparability, but does not prevent later differential care, measurement, or recording.
• “A group difference proves access caused it.” The difference may have other causes. Evidence is needed for the steps linking access to the outcome.
• “Any change in care is bias.” Whether it is bias depends on the intended estimand. Care delivered may be part of the effect of assignment under actual trial conditions, even if it complicates interpretation of a treatment effect under standardized care.
• “Adjust for every changed variable.” A post-access behavior may be a mediator. Adjusting for it can change the question being answered and may create other biases.